Metastatic Colorectal Cancer Patient With Microsatellite Stability and BRAF(V600E) Mutation Showed a Complete Metabolic Response to PD-1 Blockade and Bevacizumab: A Case Report

A vast majority of colorectal cancer (CRC) patients with microsatellite stability (MSS) or proficient mismatch repair (pMMR) are refractory to immunotherapeutic strategies. The current research focusses on the combined treatment strategies for identification and optimization in order to improve the...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Chongkai, Lin, Jietao, Zhang, Tao, Luo, Jiajun, Nie, Duorui, Li, Meng, Hu, Xue, Zheng, Yating, Huang, Xuewu, Xiao, Zhiwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112237/
https://www.ncbi.nlm.nih.gov/pubmed/33987088
http://dx.doi.org/10.3389/fonc.2021.652394

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112237/
https://www.ncbi.nlm.nih.gov/pubmed/33987088
http://dx.doi.org/10.3389/fonc.2021.652394

Ejemplares similares